Fertilo In Vitro Research Study and Trial
Public ClinicalTrials.gov record NCT06858111. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase III Randomized Control Trial to Investigate the Safety and Efficacy of Fertilo Versus Medicult In Vitro Maturation (IVM)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this clinical trial is to evaluate the safety and efficacy of using Fertilo for In vitro maturation (IVM) in participants 18-35 years of age. The main question it aims to answer is whether the use of Fertilo is superior to using Medicult IVM for In vitro maturation. Researchers will compare the number of ongoing pregnancies at 12 weeks gestation for participants in each arm. * Arm 1 participants will have all cumulus oocyte complexes (COCs), or eggs surrounded by helper cells, cultured in Fertilo for 30 hours. * Arm 2 participants will have all cumulus oocyte complexes (COCs), or eggs surrounded by helper cells, cultured in Medicult IVM for 30 hours.
Study identification
- NCT ID
- NCT06858111
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 500 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 35 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 16, 2025
- Primary completion
- Apr 30, 2027
- Completion
- Dec 31, 2027
- Last update posted
- Sep 1, 2026
2025 – 2028
United States locations
- U.S. sites
- 15
- U.S. states
- 7
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Women's Specialty & Fertility Center | Clovis | California | 93611 | Recruiting |
| HRC Fertility | Encino | California | 91436 | Recruiting |
| Florida Fertility Institute | Clearwater | Florida | 33759 | Recruiting |
| IVF Florida | Pembroke Pines | Florida | 33026 | Recruiting |
| Shady Grove Fertility | Rockville | Maryland | 20850 | Recruiting |
| Columbia University Fertility Center | New York | New York | 10019 | Recruiting |
| Reach Fertility | Charlotte | North Carolina | 28207 | Recruiting |
| Conceptions Fertility | Raleigh | North Carolina | 27607 | Recruiting |
| Aspire Fertility Dallas | Addison | Texas | 75001 | Recruiting |
| Aspire Fertility Austin | Austin | Texas | 78705 | Recruiting |
| Care Fertility | Bedford | Texas | 76022 | Recruiting |
| Dallas Fort Worth Fertility Associates | Dallas | Texas | 75231 | Recruiting |
| Aspire Fertility San Antonio | San Antonio | Texas | 78528 | Recruiting |
| Shady Grove Houston | Webster | Texas | 77598 | Recruiting |
| Utah Fertility Center | Pleasant Grove | Utah | 84062 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06858111, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 1, 2026 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06858111 live on ClinicalTrials.gov.